pdufa.bio
CalendarReadoutsDevicesDecisionsApprovals/yrTrial oddsLearnResearchMethodology
Home › Readouts › December 2026

December 2026 clinical-trial readouts

trial-readout estimates for December 2026, each row linked to its primary source. Readout dates are estimated primary-completion windows from ClinicalTrials.gov and shift.
← November 2026January 2027 →
103 readouts
EXEL · Dec 2026 (est.)
Cabozantinib — Metastatic Renal Cell Carcinoma
CNTA · Dec 2026 (est.)
cleminorexton — Narcolepsy Type 1
BEAM · Dec 2026 (est.)
BEAM-302 — Lymphoblastic Lymphoma
BIIB · Dec 2026 (est.)
Felzartamab — Antibody-mediated Rejection
BMY · Dec 2026 (est.)
Nivolumab — Non Small Cell Lung Cancer
BRTX · Dec 2026 (est.)
BRTX-100 — Lumbar Disc Disease
CGEM · Dec 2026 (est.)
CLN-081 — SLE
CMPX · Dec 2026 (est.)
CTX-009 — Biliary Tract Cancer
CNTX · Dec 2026 (est.)
Onapristone ER — Mesothelin-Expressing Tumors
CORT · Dec 2026 (est.)
Relacorilant — Cushing Syndrome
DCTH · Dec 2026 (est.)
Cisplatin and Gemcitabine — Refractory Metastatic Colorectal Cancer
DMAC · Dec 2026 (est.)
Recombinant human tissue kallikrein — Acute Stroke
DSGN · Dec 2026 (est.)
DT-168 — Friedreich Ataxia
EIKN · Dec 2026 (est.)
EIK1001 — Solid Tumor, Adult
ENTA · Dec 2026 (est.)
Zelicapavir — RSV Infection
BCDA · Dec 2026 (est.)
Autologous cell therapy — Heart Failure, Systolic
EPRX · Dec 2026 (est.)
EP-104GI — Eosinophilic Esophagitis
BHVN · Dec 2026 (est.)
BHV-7000 — Focal Epilepsy
ABVX · Dec 2026 (est.)
ABX464 — Moderately to Severely Active Crohn Disease
AGEN · Dec 2026 (est.)
Balstilimab — Refractory Metastatic Colorectal Cancer
ALMS · Dec 2026 (est.)
Open-Label Envudeucitinib — Plaque Psoriasis
ALZN · Dec 2026 (est.)
AL001 — Bipolar I Disorder
ANRO · Dec 2026 (est.)
ALTO-300 — Major Depressive Disorder
APGE · Dec 2026 (est.)
APG777 — Atopic Dermatitis
ARDX · Dec 2026 (est.)
Tenapanor — Synucleinopathy
ARWR · Dec 2026 (est.)
Plozasiran — Myotonic Dystrophy 1
AVIR · Dec 2026 (est.)
Bemnifosbuvir-Ruzasvir — HEPATITIS C VIRUS CHRONIC INFECTION
AVLN · Dec 2026 (est.)
AP01 — Idiopathic Pulmonary Fibrosis (IPF)
ADCT · Dec 2026 (est.)
Loncastuximab Tesirine — Diffuse Large B-Cell Lymphoma
AXSM · Dec 2026 (est.)
AXS-14 — Excessive Sleepiness
MDGL · Dec 2026 (est.)
Resmetirom — NASH
MNPR · Dec 2026 (est.)
Clonidine HCl Mucoadhesive Buccal Tablet — Solid Tumor, Adult
MRK · Dec 2026 (est.)
Pembrolizumab — Squamous Cell Cancer of Head and Neck
NKTX · Dec 2026 (est.)
NKX019 — Systemic Lupus Erythematosus
ONC · Dec 2026 (est.)
Zanubrutinib — Waldenstrom Macroglobulinemia
ORIC · Dec 2026 (est.)
ORIC-114 — Solid Tumors
PBYI · Dec 2026 (est.)
neratinib — Breast Cancer
PFE · Dec 2026 (est.)
Elranatamab — Multiple Myeloma
PHAT · Dec 2026 (est.)
Vonoprazan — Eosinophilic Esophagitis
RANI · Dec 2026 (est.)
PG-102 — Obesity
RCUS · Dec 2026 (est.)
Quemliclustat — Borderline Resectable Pancreatic Adenocarcinoma
RGNX · Dec 2026 (est.)
Ranibizumab — AMD
RNAC · Dec 2026 (est.)
Decartes-08 — Systemic Lupus Erythematosus (SLE)
MDWD · Dec 2026 (est.)
EscharEx — Venous Leg Ulcer (VLU)
MANE · Dec 2026 (est.)
VDPHL01 — Androgenetic Alopecia
LXEO · Dec 2026 (est.)
LX1001 — Arrhythmogenic Cardiomyopathy
GLSI · Dec 2026 (est.)
GLSI-100 — Breast Cancer
GNLX · Dec 2026 (est.)
olvimulogene nanivacirepvec — SCLC, Extensive Stage
GOSS · Dec 2026 (est.)
Seralutinib — Pulmonary Arterial Hypertension
IMMX · Dec 2026 (est.)
NXC-201 CAR-T — Light Chain (AL) Amyloidosis
INO · Dec 2026 (est.)
VGX-3100 — BRCA1/2 Mutation
IONS · Dec 2026 (est.)
Donidalorsen — Hereditary Angioedema
IXHL · Dec 2026 (est.)
IHL-42X Low Dose — Obstructive Sleep Apnea
JAZZ · Dec 2026 (est.)
CPX-351 — Acute Myeloid Leukemia (AML) in Remission
KPTI · Dec 2026 (est.)
Rituximab — Relapsed/Refractory Diffuse Large B-cell Lymphoma
KRYS · Dec 2026 (est.)
KB803 — Dystrophic Epidermolysis Bullosa
KZIA · Dec 2026 (est.)
GDC-0084 — Primary Central Nervous System Lymphoma
LTRN · Dec 2026 (est.)
Tavocept(BNP7787) in combination with cisplatin and either docetaxel or paclitaxel — Adenocarcinoma of Lung
SMMT · Dec 2026 (est.)
Ivonescimab — Stomach Cancer Stage IV
TVTX · Dec 2026 (est.)
Pegtibatinase — Proteinuric Renal Disease
VNDA · Dec 2026 (est.)
VQW-765 — Social Anxiety Disorder (SAD)
UTHR · Dec 2026 (est.)
Ralinepag — PAH
TRAW · Dec 2026 (est.)
rigosertib — Influenza
VIR · Dec 2026 (est.)
Tobevibart — Viral Hepatitis
TARA · Dec 2026 (est.)
Choline Chloride for Injection — Lymphatic Malformation
SNDX · Dec 2026 (est.)
Revumenib — Leukemia
ABUS · Dec 2026 (est.)
AB-729 — Chronic Hepatitis B
ZNTL · Dec 2026 (est.)
Investigator's choice of Chemotherapy — High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
XNCR · Dec 2026 (est.)
XMAB20717 — Biliary Tract Cancer
PFE · Dec 2026 (est.)
Mevrometostat — Metastatic Castration-Resistant Prostate Cancer
CRDF · Dec 2026 (est.)
Onvansertib — Breast Cancer
ENSC · Dec 2026 (est.)
PF614 capsule — Pharmacokinetics
SNY · Dec 2026 (est.)
Rilzabrutinib — Focal Segmental Glomerulosclerosis
BPTH · Dec 2026 (est.)
BP1001 in combination with Ventoclax plus decitabine — Poliomyelitis
KARD · Dec 2026 (est.)
danicamtiv — Hypertension
ICLR · Dec 2026 (est.)
HT-001 — Acneiform Eruption Due to Chemical
SNDX · Dec 2026 (est.)
Revumenib — Acute Myeloid Leukemia
SUPN · Dec 2026 (est.)
BIS-001 — Focal Impaired Awareness Seizures
ARVN · Dec 2026 (est.)
ARV-471 — Breast Cancer
MNOV · Dec 2026 (est.)
MN-166 — Diabetes Mellitus, Type 2
PBYI · Dec 2026 (est.)
neratinib — Lung Cancer Metastatic
PFE · Dec 2026 (est.)
Palbociclib — Breast Cancer
PLYX · Dec 2026 (est.)
PLX-200 — Juvenile Neuronal Ceroid Lipofuscinosis
SYK · Dec 2026 (est.)
Ropivacaine — Sarcoma
TARS · Dec 2026 (est.)
TP-03 — Ocular Rosacea
VIR · Dec 2026 (est.)
Tobevibart — Viral Hepatitis
ACAD · Dec 2026 (est.)
ACP-204 — Autism Spectrum Disorder
ACTU · Dec 2026 (est.)
Losartan — Pancreatic Adenocarcinoma
ADAG · Dec 2026 (est.)
Pembrolizumab — Advanced Solid Tumor
ADCT · Dec 2026 (est.)
Loncastuximab Tesirine — Chronic Lymphocytic Leukemia
ANNX · Dec 2026 (est.)
Tanruprubart — Guillain-Barre Syndrome
ARVN · Dec 2026 (est.)
ARV-471 — Breast Cancer
NVO · Dec 2026 (est.)
Semaglutide — Intestinal Mucositis
JAZZ · Dec 2026 (est.)
Zanidatamab — Breast Cancer
INSM · Dec 2026 (est.)
Treprostinil Palmitil Inhalation Powder — Pulmonary Arterial Hypertension
BCAX · Dec 2026 (est.)
Ficerafusp alfa — Head and Neck Squamous Cell Carcinoma
CERO · Dec 2026 (est.)
CER-1236 — AML
CLDX · Dec 2026 (est.)
Barzolvolimab — Breast Cancer
CMND · Dec 2026 (est.)
CMND-100 — Alcohol Use Disorder
ESLA · Dec 2026 (est.)
EB103 — B-Cell Non-Hodgkin's Lymphoma (NHL)
EXEL · Dec 2026 (est.)
XL-092 — Hepatocellular Carcinoma
FBRX · Dec 2026 (est.)
FB102 — Vitiligo
INO · Dec 2026 (est.)
VGX-3100 — Glioblastoma
Looking for an approval probability for these? We deliberately don't publish one — here's why, and what we show instead (verified history + base rates).